New possibilities for lipid level control using inclisiran - prospects for interaction between a cardiologist and a neurologist

• Main Authors: A. B. Skiba (Author), M. V. Menzorov (Author), V. D. Puchek (Author), I. M. Buchin (Author), I. I. Polyakov (Author), E. N. Menzorova (Author)
• Format: Book
• Published: Столичная издательская компания, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Dyslipidemia is one of the most significant modifiable cardiovascular risk factors. The change in the modern paradigm for dyslipidemia treatment from high-intensity statin therapy to high-intensity lipid-lowering therapy makes it possible to more often use new drug classes to achieve the target leve...